Invention Grant
- Patent Title: Oncolytic rhabdovirus
- Patent Title (中): 溶瘤性弹状病毒
-
Application No.: US12441494Application Date: 2007-09-17
-
Publication No.: US08481023B2Publication Date: 2013-07-09
- Inventor: David Stojdl , Christopher Brown , John Bell
- Applicant: David Stojdl , Christopher Brown , John Bell
- Applicant Address: CA Ottawa, Ontario
- Assignee: Ottawa Hospital Research Institute
- Current Assignee: Ottawa Hospital Research Institute
- Current Assignee Address: CA Ottawa, Ontario
- Agency: Morgan, Lewis & Bockius LLP
- International Application: PCT/US2007/078673 WO 20070917
- International Announcement: WO2009/016433 WO 20090205
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A01N63/00
Abstract:
Embodiments of the invention include compositions and methods related to non-VSV rhabdoviruses and their use as anti-cancer therapeutics. Such rhabdoviruses possess tumor cell killing properties in vitro and in vivo.
Public/Granted literature
- US20110052539A1 ONCOLYTIC RHABDOVIRUS Public/Granted day:2011-03-03
Information query
